title: Phase II clinical trial of imatinib mesylate in therapy of KIT and/or PDGFRalpha-expressing Ewing sarcoma family of tumors and desmoplastic small round cell tumors.
authors.affiliation: Department of Medical Oncology, City of Hope Comprehensive Cancer Center, 1500 E. Duarte Road, Duarte, CA 91010, USA. jchao@coh.org
authors.forename: Joseph
authors.initials: J
authors.lastname: Chao
authors.forename: G Thomas
authors.initials: GT
authors.lastname: Budd
authors.forename: Peiguo
authors.initials: P
authors.lastname: Chu
authors.forename: Paul
authors.initials: P
authors.lastname: Frankel
authors.forename: Dolores
authors.initials: D
authors.lastname: Garcia
authors.forename: Maribel
authors.initials: M
authors.lastname: Junqueira
authors.forename: Sofia
authors.initials: S
authors.lastname: Loera
authors.forename: George
authors.initials: G
authors.lastname: Somlo
authors.forename: Judith
authors.initials: J
authors.lastname: Sato
authors.forename: Warren A
authors.initials: WA
authors.lastname: Chow